Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS)
V. Descamps(Assistance Publique – Hôpitaux de Paris), A. Barbaud(Sorbonne Université), M. Avenel-Audran(Centre Hospitalier Universitaire d'Angers), B. Sassolas(Centre Hospitalier Régional Universitaire de Brest), B. Milpied(Hôpital Saint-André), P. Girardin, Bénédicte Lebrun‐Vignes(Sorbonne Université), P. Mathelier‐Fusade(Sorbonne Université), P. Modiano(Hôpital Saint-Vincent-de-Paul), H. Assier(Centre Hospitalier Universitaire Henri-Mondor), B. Ben Saïd(Hôpital Edouard Herriot), M.T. Guinnepain(Hôpital Lariboisière), F. Truchetet(Hôpital Privé Marseille Beauregard)
Cited by 160
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|429
Chromosomally integrated human herpesvirus 6: questions and answers
|Reviews in Medical Virology|2011|378